title: Current technology: devices available for destination therapy.
abstract: Left ventricular assist device therapy as a destination therapy for end-stage heart failure has made a large leap with continuous flow devices. Continuous flow does not seem to have a detrimental effect on end-organ function, at least in the midterm. Various expected and unexpected complications have been reported associated with this technology. More experience and research are warranted.
authors: Department of Surgery, Columbia University Medical Center, Milstein Hospital Building, New York, NY 10032, USA.
authors: Hiroo
authors: H
authors: Takayama
authors: Jonathan A
authors: JA
authors: Yang
authors: Yoshifumi
authors: Y
authors: Naka
mesh_terms: D006333:Heart Failure / Q000628:therapy*; D006353:Heart-Assist Devices / Q000592:standards / Q000639:trends*; D006801:Humans; D011474:Prosthesis Design / Q000639:trends*; D011475:Prosthesis Failure / Q000639:trends; D016032:Randomized Controlled Trials as Topic; D013673:Technology Assessment, Biomedical